Shehzad Basaria
Physician · Brigham and Women's Hospital
Credentials: · · · ·
History
Research
Adverse events associated with testosterone administration
New England Journal of Medicine · 2010 · First of 27 authors · 1,113 citations
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
The Journal of Clinical Endocrinology & Metabolism · 2005 · 808 citations
Adverse effects of androgen deprivation therapy and strategies to mitigate them
Review · European Urology · 2015 · 674 citations
- SB
70 papers

27 papers
- GH
21 papers · 3 as a fellow

19 papers

15 papers

13 papers
- GC
12 papers
- JE
12 papers
Grants
- 2020–2027
Androgen Replacement to Improve Patient-Important Outcomes in Men with Opioid-Induced Hypogonadism
National Institute on Aging · R01
Contact PI · $4M · Brigham and Women's Hospital
- 2019–2027
National Institute on Aging · R01
PI · $3.4M · Seattle Inst for Biomedical/Clinical Res
- 2019–2027
National Cancer Institute · R01
PI · $3.3M · Seattle Inst for Biomedical/Clinical Res
- 2021–2027
Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
National Institute on Aging · K24
Contact PI · $938.5K · Brigham and Women's Hospital
Clinical trials
- 2026–2028
Principal investigator · Recruiting · Phase 2
Shehzad Basaria, M.D.
- 2022–2026
Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)
Principal investigator · Completed · Phase 2
Brigham and Women's Hospital
- 2022–2027
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
Principal investigator · Recruiting · Phase 2
Brigham and Women's Hospital
- 2020–2023
RESIST-ADT (Androgen Deprivation Therapy)
Principal investigator · Completed
Dana-Farber Cancer Institute



